As per the
recent BIS Research report, the ADAS and autonomous driving component market is
segmented into component type, level of autonomy, vehicle type, and region for
the purpose of study. These segments are further sub-segmented into various
categories. In case of market by component type, it is sub-segmented into
camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is
increasing rapidly in the market owing to reducing cost of LiDAR sensors and their
greater range.
Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...

Comments
Post a Comment